124 related articles for article (PubMed ID: 37357294)
21. Changes in six domains of cognitive function with reproductive and chronological ageing and sex hormones: a longitudinal study in 2411 UK mid-life women.
Kilpi F; Soares ALG; Fraser A; Nelson SM; Sattar N; Fallon SJ; Tilling K; Lawlor DA
BMC Womens Health; 2020 Aug; 20(1):177. PubMed ID: 32795281
[TBL] [Abstract][Full Text] [Related]
22. The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease.
Rosenberg PB; Mielke MM; Appleby BS; Oh ES; Geda YE; Lyketsos CG
Am J Geriatr Psychiatry; 2013 Jul; 21(7):685-95. PubMed ID: 23567400
[TBL] [Abstract][Full Text] [Related]
23. Association Between Reproductive Life Span and Incident Nonfatal Cardiovascular Disease: A Pooled Analysis of Individual Patient Data From 12 Studies.
Mishra SR; Chung HF; Waller M; Dobson AJ; Greenwood DC; Cade JE; Giles GG; Bruinsma F; Simonsen MK; Hardy R; Kuh D; Gold EB; Crawford SL; Derby CA; Matthews KA; Demakakos P; Lee JS; Mizunuma H; Hayashi K; Sievert LL; Brown DE; Sandin S; Weiderpass E; Mishra GD
JAMA Cardiol; 2020 Dec; 5(12):1410-1418. PubMed ID: 32936210
[TBL] [Abstract][Full Text] [Related]
24. Optimizing detection of Alzheimer's disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO.
Ismail Z; Leon R; Creese B; Ballard C; Robert P; Smith EE
Mol Neurodegener; 2023 Jul; 18(1):50. PubMed ID: 37516848
[TBL] [Abstract][Full Text] [Related]
25. Endogenous sex hormones, cognitive decline, and future dementia in old men.
Geerlings MI; Strozyk D; Masaki K; Remaley AT; Petrovitch H; Ross GW; White LR; Launer LJ
Ann Neurol; 2006 Sep; 60(3):346-55. PubMed ID: 16865684
[TBL] [Abstract][Full Text] [Related]
26. Associations Between Age at Menopause, Vascular Risk, and 3-Year Cognitive Change in the Canadian Longitudinal Study on Aging.
Wood Alexander M; Wu CY; Coughlan GT; Puri T; Buckley RF; Palta P; Swardfager W; Masellis M; Galea LAM; Einstein G; Black SE; Rabin JS
Neurology; 2024 May; 102(9):e209298. PubMed ID: 38569140
[TBL] [Abstract][Full Text] [Related]
27. Age at menopause and all-cause and cause-specific dementia: a prospective analysis of the UK Biobank cohort.
Hao W; Fu C; Dong C; Zhou C; Sun H; Xie Z; Zhu D
Hum Reprod; 2023 Sep; 38(9):1746-1754. PubMed ID: 37344154
[TBL] [Abstract][Full Text] [Related]
28. Association of a functional polymorphism in the cholesteryl ester transfer protein (CETP) gene with memory decline and incidence of dementia.
Sanders AE; Wang C; Katz M; Derby CA; Barzilai N; Ozelius L; Lipton RB
JAMA; 2010 Jan; 303(2):150-8. PubMed ID: 20068209
[TBL] [Abstract][Full Text] [Related]
29. Healthcare and Financial Decision Making and Incident Adverse Cognitive Outcomes among Older Adults.
Stewart CC; Yu L; Wilson RS; Bennett DA; Boyle PA
J Am Geriatr Soc; 2019 Aug; 67(8):1590-1595. PubMed ID: 30882910
[TBL] [Abstract][Full Text] [Related]
30. Statin Initiation and Risk of Incident Alzheimer Disease and Cognitive Decline in Genetically Susceptible Older Adults.
Rajan KB; Mcaninch EA; Wilson RS; Dhana A; Evans-Lacko S; Evans DA
Neurology; 2024 Apr; 102(7):e209168. PubMed ID: 38447103
[TBL] [Abstract][Full Text] [Related]
31. Peripheral inflammatory biomarkers are associated with cognitive function and dementia: Framingham Heart Study Offspring cohort.
Chen J; Doyle MF; Fang Y; Mez J; Crane PK; Scollard P; ; Satizabal CL; Alosco ML; Qiu WQ; Murabito JM; Lunetta KL
Aging Cell; 2023 Oct; 22(10):e13955. PubMed ID: 37584418
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of abnormal Alzheimer's disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples.
Wolfsgruber S; Molinuevo JL; Wagner M; Teunissen CE; Rami L; Coll-Padrós N; Bouwman FH; Slot RER; Wesselman LMP; Peters O; Luther K; Buerger K; Priller J; Laske C; Teipel S; Spottke A; Heneka MT; Düzel E; Drzezga A; Wiltfang J; Sikkes SAM; van der Flier WM; Jessen F;
Alzheimers Res Ther; 2019 Jan; 11(1):8. PubMed ID: 30654834
[TBL] [Abstract][Full Text] [Related]
33. Association of glial and neuronal degeneration markers with Alzheimer's disease cerebrospinal fluid profile and cognitive functions.
Teitsdottir UD; Jonsdottir MK; Lund SH; Darreh-Shori T; Snaedal J; Petersen PH
Alzheimers Res Ther; 2020 Aug; 12(1):92. PubMed ID: 32753068
[TBL] [Abstract][Full Text] [Related]
34. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
[TBL] [Abstract][Full Text] [Related]
35. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
Burnham SC; Bourgeat P; Doré V; Savage G; Brown B; Laws S; Maruff P; Salvado O; Ames D; Martins RN; Masters CL; Rowe CC; Villemagne VL;
Lancet Neurol; 2016 Sep; 15(10):1044-53. PubMed ID: 27450471
[TBL] [Abstract][Full Text] [Related]
36. Association between Body Mass Index and Diabetes Mellitus Are Mediated through Endogenous Serum Sex Hormones among Menopause Transition Women: A Longitudinal Cohort Study.
He L; Fan B; Li C; Qu Y; Liu Y; Zhang T
Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767197
[TBL] [Abstract][Full Text] [Related]
37. Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers.
Mattsson-Carlgren N; Salvadó G; Ashton NJ; Tideman P; Stomrud E; Zetterberg H; Ossenkoppele R; Betthauser TJ; Cody KA; Jonaitis EM; Langhough R; Palmqvist S; Blennow K; Janelidze S; Johnson SC; Hansson O
JAMA Neurol; 2023 Apr; 80(4):360-369. PubMed ID: 36745413
[TBL] [Abstract][Full Text] [Related]
38. Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease.
Dicks E; Vermunt L; van der Flier WM; Visser PJ; Barkhof F; Scheltens P; Tijms BM;
Neuroimage Clin; 2019; 22():101786. PubMed ID: 30921610
[TBL] [Abstract][Full Text] [Related]
39. Sex differences in plasma p-tau181 associations with Alzheimer's disease biomarkers, cognitive decline, and clinical progression.
Tsiknia AA; Edland SD; Sundermann EE; Reas ET; Brewer JB; Galasko D; Banks SJ;
Mol Psychiatry; 2022 Oct; 27(10):4314-4322. PubMed ID: 35768637
[TBL] [Abstract][Full Text] [Related]
40. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
